Pharmacological treatment of anxiety disorders: Current treatments and future directions

Highlights ► Incomplete treatment response is common and should be studied using novel methods. ► Neurogenesis-promoting drugs appear promising but are in early development. ► Drugs that enhance memory consolidation may augment exposure-based therapy, but long-term data are needed. ► Adjunctive use...

Full description

Saved in:
Bibliographic Details
Published in:Journal of anxiety disorders 2012-12, Vol.26 (8), p.833-843
Main Authors: Farach, Frank J, Pruitt, Larry D, Jun, Janie J, Jerud, Alissa B, Zoellner, Lori A, Roy-Byrne, Peter P
Format: Article
Language:English
Subjects:
Adult and adolescent clinical studies
Anti-Anxiety Agents - therapeutic use
Antidepressants
Anxiety disorders
Anxiety Disorders - drug therapy
Anxiety disorders. Neuroses
Biological and medical sciences
Drug Therapy - trends
Efficacy
Humans
Manipulation
Medical sciences
Memory
Memory consolidation
Pathophysiological aspects
Pharmacotherapy
Psychedelics
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Treatment methods
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► Incomplete treatment response is common and should be studied using novel methods. ► Neurogenesis-promoting drugs appear promising but are in early development. ► Drugs that enhance memory consolidation may augment exposure-based therapy, but long-term data are needed. ► Adjunctive use of psychedelic and narcotic drugs with psychotherapy has poor empirical support.
ISSN:0887-6185
1873-7897
DOI:10.1016/j.janxdis.2012.07.009